Organogenesis Holdings Forecast, price target & analysts
Organogenesis Holdings Target price 2026 - Analyst rating & recommendation
Organogenesis Holdings Classifications & Recommendation
Organogenesis Holdings Price Target
| Target Price | $2.04 |
| Price | $1.38 |
| Potential |
47.83%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Organogenesis Holdings 2027 .
The average Organogenesis Holdings target price is $2.04.
This is
47.83%
register free of charge
$2.10
52.17%
register free of charge
$2.02
46.38%
register free of charge
|
|
| A rating was issued by 7 analysts: 0 Analysts recommend Organogenesis Holdings to buy, 4 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Organogenesis Holdings stock has an average upside potential 2027 of
47.83%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 564.17 | 199.97 |
| 17.04% | 64.56% | |
| EBITDA Margin | 13.20% | -49.71% |
| 65.10% | 476.59% | |
| Net Margin | 3.55% | -90.57% |
| 1,919.74% | 2,652.29% |
4 Analysts have issued a sales forecast Organogenesis Holdings 2026 . The average Organogenesis Holdings sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Organogenesis Holdings EBITDA forecast 2026. The average Organogenesis Holdings EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Organogenesis Holdings Analysts have issued a net profit forecast 2026. The average Organogenesis Holdings net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.15 | -1.41 |
| 1,600.00% | 1,040.00% | |
| P/E | negative | |
| EV/Sales | 0.74 |
4 Analysts have issued a Organogenesis Holdings forecast for earnings per share. The average Organogenesis Holdings EPS is
This results in the following potential growth metrics and future valuations:
Organogenesis Holdings...
Current Organogenesis Holdings Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | May 28 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Mar 26 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Feb 27 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Dec 26 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Dec 15 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
May 28 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Mar 26 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Feb 27 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Dec 26 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Dec 15 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Nov 20 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
